Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/2445/150708

The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer
Martínez-Bosch, Neus; Guerrero, Pedro Enrique.; Moreno, Mireia; José, Anabel; Iglesias, Mar; Munné-Collado, Jessica; Anta, Héctor; Gibert, Joan; Orozco, Carlos Alberto; Vinaixa, Judith; Fillat i Fonts, Cristina; Viñals Canals, Francesc; Navarro, Pilar
Current treatments for pancreatic ductal adenocarcinoma (PDA) are ineffective, making this the 4th leading cause of cancer deaths. Sunitinib is a broad-spectrum inhibitor of tyrosine kinase receptors mostly known for its anti-angiogenic effects. We tested the therapeutic effects of sunitinib in pancreatic cancer using the Ela-myc transgenic mouse model. We showed that Ela-myc pancreatic tumors express PDGFR and VEGFR in blood vessels and epithelial cells, rendering these tumors sensitive to sunitinib by more than only its anti-angiogenic activity. However, sunitinib treatment of Ela-myc mice with either early or advanced tumor progression had no impact on either survival or tumor burden. Further histopathological characterization of these tumors did not reveal differences in necrosis, cell differentiation, angiogenesis, apoptosis or proliferation. In stark contrast, in vitro sunitinib treatment of Ela-myc- derived cell lines showed high sensitivity to the drug, with increased apoptosis and reduced proliferation. Correspondingly, subcutaneous tumors generated from these cell lines completely regressed in vivo after sunitinib treatments. These data point at the pancreatic tumor microenvironment as the most likely barrier preventing sunitinib treatment efficiency in vivo. Combined treatments with drugs that disrupt tumor fibrosis may enhance sunitinib therapeutic effectiveness in pancreatic cancer treatment.
-Càncer de pàncrees
-Pancreas cancer
cc-by (c) Martínez-Bosch, Neus et al., 2016
http://creativecommons.org/licenses/by/3.0/es
Article
Article - Versió publicada
Impact Journals
         

Mostra el registre complet del document

Documents relacionats

Altres documents del mateix autor/a

Martinez-Bosch, Neus; Barranco, Luis E.; Orozco, Carlos A.; Moreno, Mireia; Visa, Laura; Iglesias, Mar; Oldfield, Lucy; Neoptolemos, John P.; Greenhalf, William; Earl, Julie; Carrato, Alfredo; Costello, Eithne; Navarro, Pilar
Martínez Bosch, Neus; Cristóbal, Helena; Iglesias, Mar; Gironella, Meritxell; Barranco, Luis; Visa, Laura; Calafato, Domenico; Jiménez-Parrado, Silvia; Earl, Julie; Carrato, Alfredo; Manero-Rupérez, Noemí; Moreno Merino, Mireia; Morales, Albert; Guerra, Carmen; Navarro, Pilar; García de Frutos, Pablo
Mancebo Moreno, Gemma; Sole-Sedeno, J.M.; Pino, O.; Miralpeix, E.; Mojal, Sergio; Garrigos, L.; Lloveras Rubio, Belen; Navarro Medrano, Pilar; Gibert, Joan; Lorenzo Perez, Marta; Aran, Iris; Carreras Collado, Ramón; Alameda Quitllet, Francisco
Ortiz Sanjuán, Francisco; Blanco, Ricardo; Riancho Zarrabeitia, Leyre; Castañeda, Santos; Olivé, Alejandro; Riveros, Anne; Velloso Feijoo, María L.; Narváez García, Francisco Javier; Jiménez Moleón, Inmaculada; Maiz Alonso, Olga; Ordóñez, Carmen; Bernal, José A.; Hernández, María V.; Sifuentes Giraldo, Walter A.; Gómez Arango, Catalina; Galíndez Agirregoikoa, Eva; Blanco Madrigal, Juan; Ortiz Santamaria, Vera; Blanco Barnusell, Jordi del; Dios, Juan R. de; Moreno, Mireia; Fiter, Jordi; Riscos, Marina de los; Carreira, Patricia; Rodriguez Valls, María J.; González Vela, M. Carmen; Calvo Río, Vanesa; Loricera, Javier; Palmou Fontana, Natalia; Pina, Trinitario; Llorca Díaz, Javier; González Gay, Miguel A.
Moreno, Mireia; Lisbona Pérez, María Pilar; Gallardo Hernández, Fernando; Deza Vargas, Luis Gustavo; Ferran Farrés, Marta; Pontes, Caridad; Luelmo, Jesús; Maymó Guarch, Joan; Gratacós, Jordi